A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

Depressive Disorder ◽

Adjunctive Therapy ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study

BMC Geriatrics ◽

10.1186/1471-2318-4-11 ◽

2004 ◽

Vol 4 (1) ◽

Cited By ~ 29

Author(s):

Madelaine M Wohlreich ◽

Craig H Mallinckrodt ◽

John G Watkin ◽

Donald P Hay

Keyword(s):

Depressive Disorder ◽

Term Treatment ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Label Study ◽

Long Term Treatment

P.2.f.010 Long-term open-label study of adjunctive treatment with edivoxetine for patients with major depressive disorder (MDD) who are partial responders to SSRI treatment

European Neuropsychopharmacology ◽

10.1016/s0924-977x(13)70634-5 ◽

2013 ◽

Vol 23 ◽

pp. S401-S402

Author(s):

S. Ball ◽

S. Atkinson ◽

J.D. Sparks ◽

M. Bangs ◽

C. Goldberger ◽

...

Keyword(s):

Depressive Disorder ◽

Adjunctive Treatment ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Label Study ◽

Ssri Treatment

An open-label study of adjunctive repetitive transcranial magnetic stimulation (rTMS) for partial remission in major depressive disorder

International Journal of Psychiatry in Clinical Practice ◽

10.3109/13651501.2011.632681 ◽

2012 ◽

Vol 16 (2) ◽

pp. 98-102 ◽

Cited By ~ 4

Author(s):

Chawanun Charnsil ◽

Sirijit Suttajit ◽

Vudhichai Boonyanaruthee ◽

Samornsri Leelarphat

Keyword(s):

Transcranial Magnetic Stimulation ◽

Depressive Disorder ◽

Partial Remission ◽

Magnetic Stimulation ◽

Repetitive Transcranial Magnetic Stimulation ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram

Journal of Affective Disorders ◽

10.1016/j.jad.2019.03.040 ◽

2019 ◽

Vol 250 ◽

pp. 114-122 ◽

Cited By ~ 7

Author(s):

Oleg A. Levada ◽

Alexandra S. Troyan

Keyword(s):

Depressive Disorder ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Label Study ◽

Functional Relationships

Low‐ and high‐dose aripiprazole augmentation and plasma levels of homovanillic acid in major depressive disorder: A randomized, open‐label study

Human Psychopharmacology Clinical and Experimental ◽

10.1002/hup.2696 ◽

2019 ◽

Vol 34 (3) ◽

pp. e2696 ◽

Cited By ~ 1

Author(s):

Sho Horikoshi ◽

Itaru Miura ◽

Mizue Ichinose ◽

Shinnosuke Yamamoto ◽

Masashi Ito ◽

...

Keyword(s):

Depressive Disorder ◽

Plasma Levels ◽

Homovanillic Acid ◽

High Dose ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder

Asia-Pacific Psychiatry ◽

10.1111/appy.12060 ◽

2013 ◽

Vol 6 (2) ◽

pp. 152-160 ◽

Cited By ~ 5

Author(s):

Dan Wang ◽

Zexuan Li ◽

Lingjiang Li ◽

Wei Hao

Keyword(s):

Depressive Disorder ◽

Sleep Quality ◽

Real World ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Reboxetine augmentation of fluoxetine for patients with major depressive disorder: An 8-week open-label study

European Neuropsychopharmacology ◽

10.1016/s0924-977x(02)80209-7 ◽

2002 ◽

Vol 12 ◽

pp. 205 ◽

Cited By ~ 2

Author(s):

M. Rapaport ◽

C. Wilcox ◽

J. Heiser ◽

P. Londborg ◽

G. Schwartz

Keyword(s):

Depressive Disorder ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Duloxetine in the treatment of major depressive disorder: an open-label study

BMC Psychiatry ◽

10.1186/1471-244x-7-43 ◽

2007 ◽

Vol 7 (1) ◽

Cited By ~ 18

Author(s):

James I Hudson ◽

David G Perahia ◽

Inmaculada Gilaberte ◽

Fujun Wang ◽

John G Watkin ◽

...

Keyword(s):

Depressive Disorder ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry ◽

10.1016/j.pnpbp.2007.07.019 ◽

2008 ◽

Vol 32 (1) ◽

pp. 100-106 ◽

Cited By ~ 8

Author(s):

Jay D. Amsterdam ◽

Justine Shults ◽

Nancy Rutherford

Keyword(s):

Chronic Fatigue Syndrome ◽

Depressive Disorder ◽

Chronic Fatigue ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Label Study ◽

Fatigue Syndrome

An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline re-uptake inhibitor, in patients with DSM-III-R major depressive disorder

Biological Psychiatry ◽

10.1016/s0006-3223(97)87892-4 ◽

1997 ◽

Vol 42 (1) ◽

pp. 239S

Author(s):

M. Berk ◽

A.D. du Plessis ◽

M. Birkett ◽

D. Richardt

Keyword(s):

Depressive Disorder ◽

Open Label ◽

Major Depressive ◽

Open Label Study ◽

Label Study ◽

Uptake Inhibitor ◽

Duloxetine Hydrochloride